Treatment of keloid by intralesional injections of interferon alfa-2B
Espinassouze, F.; Heid, E.; Grosshans, E.
Annales de Dermatologie et de Venereologie 120(9): 629-630
1993
ISSN/ISBN: 0151-9638 PMID: 8161119 Document Number: 409421
Document emailed within 1 workday
Related Documents
Fernández, I.; Castellano, G.; Canga, F.; Colina, F.; García, H.; Fuertes, A.; Casis, B.; Martín, A.; Solís, J.A. 1995: A comparative randomized controlled study of the efficacy of interferon alfa-2b and interferon alfa-2a in the treatment of chronic hepatitis C Gastroenterologia y Hepatologia 18(2): 66-72Wong, J. B.; Nevens, F. 2002: Cost-effectiveness of peginterferon alfa-2b plus ribavirin compared to interferon alfa-2b plus ribavirin as initial treatment of chronic hepatitis C in Belgium Acta Gastro-Enterologica Belgica 65(2): 110-111
Chang, K.H.; Rojhirunsakool, S.; Goldberg, L.J. 2009: Treatment of severe alopecia areata with intralesional steroid injections Journal of Drugs in Dermatology: Jdd 8(10): 909-912
Cohen, H.A.; Wahaba, A. 1979: Treatment of leishmaniasis recidivens with intralesional injections of emetine hydrochloride: a case report Acta Dermato-Venereologica 59(6): 549-552
2001: Treatment of chronic hepatitis B: interferon alfa first Prescrire International 10(51): 17-21
Adam, Z. 1993: Interferon-alfa in the treatment of myeloproliferative diseases Vnitrni Lekarstvi 39(12): 1210-1218
Nevens, F.; Van Vlierberghe, H.; D'Heygere, E.; Delwaide, J.; Adler, M.; Henrion, J.; Lenaerts, A.; Hendlisz, A.; Michielsen, P.; Bastens, B.; Brenard, R.; Laureys, A. 2010: A randomized, open-label, multicenter study evaluating the efficacy of peginterferon alfa-2a versus interferon alfa-2a, in combination with ribavirin, in naïve and relapsed chronic hepatitis C patients Acta Gastro-Enterologica Belgica 73(2): 223-228
Cianciara, J.; Laskus, T.; Hryniewicz, H.; Jabłońska, J.; Loch, T. 1991: Treatment of chronic hepatitis B with interferon alfa-2b (Intron A) Przeglad Epidemiologiczny 45(4): 315-320
Neuwirtová, R.; Cermák, J.; Kvasnicka, J.; Sedlácková, M. 1989: Treatment of hairy-cell leukemia using interferon alfa Casopis Lekaru Ceskych 128(34): 1065-1070
Alecu, M.; Ghyka, G.; Hălălău, F.; Călugăru, A.; Coman, G. 1990: Intralesional human leukocyte interferon treatment in the non-AIDS related Kaposi's sarcoma Medecine Interne 28(1): 61-67
Gómez-Almaguer, D.; Jaime-Pérez, J.C.; Herrera-Garza, J.L.; González-Llano, O. 1998: Intermittent interferon alfa in the treatment of hairy cell leukemia Revista de Investigacion Clinica; Organo del Hospital de Enfermedades de la Nutricion 50(4): 331-334
Zouboulis, C.C.; Orfanos, C.E. 1998: Treatment of Adamantiades-Behçet disease with systemic interferon alfa Archives of Dermatology 134(8): 1010-1016
Kuzel, T.M.; Gilyon, K.; Springer, E.; Variakojis, D.; Kaul, K.; Bunn, P.A.; Evans, L.; Roenigk, H.H.; Rosen, S.T. 1990: Interferon alfa-2a combined with phototherapy in the treatment of cutaneous T-cell lymphoma Journal of the National Cancer Institute 82(3): 203-207
Bernhard, H.; Klein, O.; Meyer zum Büschenfelde, K.H.; Knuth, A. 1992: Treatment of refractory colorectal carcinomas with fluorouracil, folinic acid, and interferon alfa-2a Seminars in Oncology 19(2 Suppl 3: 204-207
Castañeda, C.; García, E.; Grá, B.; Nodarse-Cuní, H.; García, W.; Andrade, M.; Martínez, G.; Trujillo, M.ía.; Soto, G.; Amoroto, M.é; Viada, C.; López-Saura, P. 2002: Interferon alfa 2b treatment decreases histological activity in children with chronic hepatitis B Acta Gastroenterologica Latinoamericana 32(1): 35-42
Tulli, A.; Biele, M.M.; Capizzi, R. 1988: A possible visceralization in a case of cutaneous T cell lymphoma under treatment with recombinant interferon alfa 2 Giornale Italiano di Dermatologia e Venereologia: Organo Ufficiale Societa Italiana di Dermatologia e Sifilografia 123(5): 262
González de Dios, J.; Moya Benavent, M.; Herranz Sánchez, Y.; Juste Ruiz, M.; González Montero, R. 1996: The interferon alfa-2a treatment of the severe form of the Kasabach-Merritt syndrome with neonatal onset Anales Espanoles de Pediatria 44(2): 179-183
Termeer, C.C.; Simon, J.C.; Schöpf, E. 2001: Low-dose interferon alfa-2b for the treatment of Churg-Strauss syndrome with prominent skin involvement Archives of Dermatology 137(2): 136-138
Mattot, M.; Ninane, J.; Hamoir, M.; Moulin, D.; Mustin, V.; Vermylen, C.; Cornu, G. 1990: Combined CO2-laser and alfa recombinant interferon treatment in five children with juvenile laryngeal papillomatosis Acta Clinica Belgica 45(3): 158-163
Tóthová, E.; Stecová, N.; Kafková, A.; Fricová, M.; Svorcová, E. 2002: Occurrence of autoimmune complications in patients with chronic myelocytic leukemia during treatment with interferon alfa Vnitrni Lekarstvi 48(5): 380-383